Patient‐reported outcomes on empagliflozin treatment in glycogen storage disease type Ib: An international questionnaire study

In patients with glycogen storage disease type Ib (GSD Ib), quality of life is severely hampered by neutropenia and neutropenia‐associated symptoms. SGLT2 inhibitors are a new treatment option and have shown improved medical outcomes in more than 120 patients so far. The aim of this international qu...

Descripción completa

Detalles Bibliográficos
Autores principales: Grünert, Sarah C., Venema, Annieke, LaFreniere, Jamas, Schneider, Blair, Contreras, Enrique, Wortmann, Saskia B., Derks, Terry G. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons, Inc. 2023
Materias:
Research Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159866/
https://www.ncbi.nlm.nih.gov/pubmed/37151361
http://dx.doi.org/10.1002/jmd2.12364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10159866/
https://www.ncbi.nlm.nih.gov/pubmed/37151361
http://dx.doi.org/10.1002/jmd2.12364

Ejemplares similares